Skip to content

13F-HR filed by BRIDGER MANAGEMENT, LLC

BRIDGER MANAGEMENT, LLC filed this 13F-HR for the quarter ended 2018-12-31, filed 2019-02-14, with 34 holding rows worth $1,199,590,000.

Accession
0001166309-19-000002
Filed
2019-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2018

A holdings report, 34 entries on the cover page, a total value of $1,199,590,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,199,589,000 with VALUE read as thousands by filing date, 13F file number 028-10079. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ATARA BIOTHERAPEUTICS INC COM NEW046513107Stock2,206,917$76,668,000thousands by filing date
GODADDY INC CL A380237107Stock1,106,900$72,635,000thousands by filing date
HERON THERAPEUTICS INC427746102COM2,482,309$64,391,000thousands by filing date
POST HLDGS INC737446104COM709,796$63,264,000thousands by filing date
MEDICINES CO584688105COM3,060,671$58,581,000thousands by filing date
Morgan Stanley617446448COM1,363,307$54,055,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM4,773,718$51,031,000thousands by filing date
CHARTER COMMUNICATIONS INC N16119P108COM171,451$48,858,000thousands by filing date
MGM RESORTS INTERNATIONAL552953101COM1,986,689$48,197,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock658,785$48,032,000thousands by filing date
FIRST DATA CORP NEW COM CL A32008D106Stock2,658,994$44,964,000thousands by filing date
IRONWOOD PHARMACEUTICALS INC46333X108COMMON STOCK4,181,892$43,324,000thousands by filing date
VERISIGN INC COM92343E102Stock290,843$43,129,000thousands by filing date
ELDORADO RESORTS INC28470R102COM1,112,836$40,296,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS1,424,239$38,768,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM1,134,414$37,288,000thousands by filing date
VIASAT INC92552V100COM570,979$33,659,000thousands by filing date
GDS HLDGS LTD SPONSORED ADS36165L108ADR1,389,514$32,084,000thousands by filing date
CZR127686103Stock4,452,889$30,235,000thousands by filing date
LIBERTY BROADBAND A530307107COMMON STOCK390,292$28,027,000thousands by filing date
ROCKET PHARMACEUTICALS INC77313F106COM1,752,902$25,978,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,500,000$23,130,000thousands by filing date
SHAKE SHACK INC819047101CL A456,923$20,753,000thousands by filing date
Golden Entertainment Inc381013101Common Stock1,282,755$20,550,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM200,049$19,477,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM79,816$18,844,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock160,609$18,518,000thousands by filing date
STAAR SURGICAL CO COM PAR $0.01852312305Stock514,105$16,405,000thousands by filing date
TG THERAPEUTICS INC COM88322Q108Stock3,791,531$15,545,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC141619106COMMON STOCK536,128$15,274,000thousands by filing date
PRETIUM RESOURCES INC74139C102COMMON STOCK-FO1,651,328$13,954,000thousands by filing date
AMNEAL PHARMACEUTICALS INC03168L105COM STK CL A1,021,420$13,820,000thousands by filing date
WAVE LIFE SCIENCES LTD SHSY95308105Stock311,393$13,091,000thousands by filing date
DEXCOM INC COM252131107Stock56,457$6,764,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001166309-19-000002this filing2019-02-14acceptance time not in the bulk data set